Referências

1. Bartold PM, Dyke TEV. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 2013;62(1):203-17.
2. Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care 1993;16(1):329-34.
3. Albandar JM, Susin C, Hughes FJ. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Clin Periodontol 2018;45(suppl.20):171s-89s.
4. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20(2):12.
5. Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leitão CB, Gross JL et al. Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res 2018;32:e35.
6. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res 2007;86(3):271-5.
7. D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93(10):3989-94.
8. Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S et al. Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig 2017;21(5):1537-44.
9. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [On-line]. Disponível em <http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>. Acesso em: 10-12-2020.
10. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.
11. López NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, López R. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol 2012;83(3):267-78.
12. Bizzarro S, van der Velden U, Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: a randomized clinical trial. J Clin Periodontol 2017;44(8):833-41.
13. Montero E, López M, Vidal H, Martínez M, Virto L, Marrero J et al. Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a randomized clinical trial [On-line]. Disponível em <https://doi.org/10.1111/dom.14131>. Acesso em: 15-7-2020.
14. Acharya A, Bhavsar N, Jadav B, Parikh H. Cardioprotective effect of periodontal therapy in metabolic syndrome: a pilot study in Indian subjects. Metab Syndr Relat Disord 2010;8(4):335-41.
15. Torumtay G, Kırzıoğlu FY, Öztürk Tonguç M, Kale B, Calapoğlu M, Orhan H. Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome. J Periodontal Res 2016;51(4):489-98.
16. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds 2017;11(8):215-25.
17. Babio N, Toledo E, Estruch R, Ros E, Martínez-González MA, Castañer O et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ 2014;186(17):649-57.
18. Cozlea DL, Farcas DM, Nagy A, Keresztesi AA, Tifrea R, Cozlea L et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J 2013;39(4):225-31.
19. D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84(3):269-73.
20. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74(8):1231-6.
21. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78.
22. Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the suita study. J Atheroscler Thromb 2017;24(5):495-507.
23. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune AN et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol 2017;109(2 suppl.1):1-76.
24. Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 2000;71(8):1375-84.
25. Saito M, Shimazaki Y, Nonoyama T, Tadokoro Y. Number of teeth, oral self-care, eating speed, and metabolic syndrome in an aged Japanese population. J Epidemiol 2019;29(1):26-32.
26. Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N et al. A cohort study on the association between periodontal disease and the development of metabolic syndrome. J Periodontol 2010;81(4):512-9.
27. Salvi GE, Franco LM, Braun TM, Lee A, Rutger Persson G, Lang NP et al. Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study. J Clin Periodontol 2010;37(1):9-16.
28. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012;55(1):21-31.
29. Peng CH, Yang YS, Chan KC, Kornelius E, Chiou JY, Huang CN. Periodontal treatment and the risks of cardiovascular disease in patients with type 2 diabetes: a retrospective cohort study. Intern Med 2017;56(9):1015-21.
30. Teshome A, Yitayeh A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis. BMC Oral Health 2016;17(1):31.
31. Sgolastra F, Gatto R, Petrucci A, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 2012;83(10):1257-69.
32. Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol 2020;47(suppl.22):257-81.
33. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 2014;15(4):277-87.
34. Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000 2017;75(1):317-29.
35. Lang NP, Bartold PM. Periodontal health. J Periodontol 2018;89(suppl.1): S9-S16.